Home / Health / Brain Tumor Risk Spurs Lawsuits Against Depo-Provera
Brain Tumor Risk Spurs Lawsuits Against Depo-Provera
12 Feb
Summary
- Depo-Provera use is linked to a higher risk of meningiomas.
- UK law firms are considering legal action against Pfizer.
- Thousands of women are already suing Pfizer in the US.

Women in the UK are being represented by law firms considering legal action against Pfizer over the contraceptive injection Depo-Provera. Studies indicate a higher risk of meningiomas, non-cancerous brain tumors, in women using the drug. These tumors can cause severe health issues including seizures, vision loss, and memory problems.
Multiple law firms in the UK have begun assessing potential cases, with some already gathering clients who have developed meningiomas after prolonged Depo-Provera use. The claims focus on Pfizer's alleged failure to adequately warn patients and regulatory bodies about these risks. This follows similar litigation in the US, where approximately 2,500 women are suing Pfizer, with a federal trial scheduled for December.
Pfizer maintains that patient safety is its top priority and that Depo-Provera has a well-established safety profile, approved in over 60 countries. However, affected women report devastating long-term health consequences, including the need for multiple surgeries and ongoing physical and cognitive impairments. The company is contesting the ongoing litigation.




